This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): rAAV8
Description: Genethon's program is based on using an AAV8 (adeno-associated virus, serotype 8) vector carrying a transgene (U7) that allows the cellular machinery to skip over an exon 53 and produce ‘quasi-dystrophin’ in the patient’s muscle.
AAV-U7 Program News
Additional information available to subscribers only: